These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 12517495)
21. Delivering effective lipid management in the managed care setting: an interview with Leslee J. Shaw, PhD. Shaw LJ Am J Manag Care; 2002 Sep; 8(12 Suppl):S323-6. PubMed ID: 12240704 [No Abstract] [Full Text] [Related]
22. WOSCOPS. West of Scotland Coronary Prevention Group. Barringer TA Lancet; 1997 Feb; 349(9049):432-3. PubMed ID: 9033494 [No Abstract] [Full Text] [Related]
23. Japan: are statins still good for everybody? Sirtori CR; Calabresi L Lancet; 2006 Sep; 368(9542):1135-6. PubMed ID: 17011926 [No Abstract] [Full Text] [Related]
24. [Reconsideration of the therapy of coronary heart disease is needed. Symposium: "Prevention and Treatment of Coronary Disease", part of the 103rd Congress of the German Society of Internal Medicine. Wiesbaden, 6 April 1997]. Dtsch Med Wochenschr; 1997 Oct; 122(42 Suppl Umdenken):1-4. PubMed ID: 9368472 [No Abstract] [Full Text] [Related]
25. [Commentary: External validity of studies on Primary Care prevention of Hypercholesterolemia]. Brotons C Aten Primaria; 2003 Nov; 32(9):514-6. PubMed ID: 14651828 [No Abstract] [Full Text] [Related]
26. Diet-heart issues in a pharmacological era. Kromhout D Lancet; 1996 Nov; 348 Suppl 1():s20-2. PubMed ID: 8918524 [No Abstract] [Full Text] [Related]
32. Health education, health promotion or drugs? Cholesterol and coronary heart disease. Colquhoun D Med J Aust; 1990 Sep; 153(5):305-6. PubMed ID: 2392086 [No Abstract] [Full Text] [Related]
33. [Clinical relevance of hypercholesterolemia and its correction]. Oganov RG; SidorenkoBA ; Gratsianskiĭ NA; Perova NV; Liakishev AA; Shevchenko OP; Belousov IuB; Markin SS; Morozova TP; Shcherbakova IA Kardiologiia; 1991 Oct; 31(10):97-112. PubMed ID: 1753600 [No Abstract] [Full Text] [Related]
34. Controversies in primary prevention among hyperlipidemic patients. McPherson R Can J Cardiol; 1999 Apr; 15 Suppl B():16B-19B. PubMed ID: 10350678 [TBL] [Abstract][Full Text] [Related]
35. Prevention of coronary heart disease with pravastatin. Davis DR N Engl J Med; 1996 May; 334(20):1334; author reply 1335. PubMed ID: 8609958 [No Abstract] [Full Text] [Related]
36. Current attempts at prevention of ischaemic heart disease. Sharland DE Gerontol Clin (Basel); 1971; 13(1):82-8. PubMed ID: 5547262 [No Abstract] [Full Text] [Related]
37. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention. Labreche DG Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850 [No Abstract] [Full Text] [Related]
39. [One year after WOSCOP, what is the correct pharmacological treatment of primary hypercholesterolemia? Réflexions du Groupe de Pharmacologie Clinique de la Société Française de Cardiologie]. Therapie; 1996; 51(6):611-4. PubMed ID: 9163995 [No Abstract] [Full Text] [Related]